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Background: Using plant viruses to produce desirable proteins in plants allows for using non-transgenic plant
hosts and if necessary, the ability to make rapid changes in the virus construct for increased or modified protein
product yields. The objective of this work was the development of advanced CMV-based protein production
systems to produce Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1) in non-transgenic plants.
Results: We used two new Cucumber mosaic virus (CMV)-based vector systems for producing the green fluorescent
protein (GFP) and more importantly, the Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1) in non-transgenic
Nicotiana benthamiana plants. These are the inducible CMVin (CMV-based inducible) and the autonomously
replicating CMVar (CMV-based advanced replicating) systems. We modified a binary plasmid containing the
complete CMV RNA 3 cDNA to facilitate insertion of desired sequences, and to give modifications of the
subgenomic mRNA 4 leader sequence yielding several variants. Quantitative RT-PCR and immunoblot analysis
showed good levels of CMV RNA and coat protein accumulation for some variants of both CMVin and CMVar. When
genes for E1 or GFP were inserted in place of the CMV coat protein, both were produced in plants as shown by
fluorescence (GFP) and immunoblot analysis. Enzymatic activity assays showed that active E1 was produced in
plants with yields up to ~ 11 μg/g fresh weight (FW) for specific variant constructs. We also compared in vitro CMV
genomic RNA reassortants, and CMV RNA 3 mutants which lacked the C’ terminal 33 amino acids of the 3A
movement protein in attempts to further increase E1 yield. Taken together specific variant constructs yielded up to
~21 μg/g FW of E1 in non-transgenic plants.
Conclusions: Intact, active E1 was rapidly produced in non-transgenic plants by using agroinfiltration with the
CMV-based systems. This reduces the time and cost compared to that required to generate transgenic plants and
still gives the comparable yields of active E1. Our modifications described here, including manipulating cloning sites
for foreign gene introduction, enhance the ease of use. Also, N. benthamiana, which is particularly suitable for
agroinfiltration, is a very good plant for transient protein production.
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Using plant viruses as vehicles for foreign protein pro-
duction in plants offers many advantages over more
traditional prokaryotic-based, and even over transgenic
plant-based protein production systems. For example,
plants are relatively easy and inexpensive to grow, plants
are able to perform post-translational protein modifica-
tions (e.g. glycosylation) not possible with prokaryotes,
and plant cells can secrete appropriately engineered pro-
teins allowing for simplified product purification [1,2].
Transgenic plants engineered to produce desirable pro-
teins offer some of these advantages, but engineered
plants require substantial time, effort and cost to de-
velop and do not offer flexibility for rapid change if
modifications to the protein product are desired. By con-
trast, using plant viruses to produce desired proteins in
plants allows for using non-transgenic plant hosts and if
necessary, the ability to make rapid changes in the virus
construct for increased or modified protein product
yields.
Cucumber mosaic virus (CMV) is the one of the
viruses that has been used for protein production in
plants [3,4]. CMV has an extremely wide plant host
range [5] which opens the door for using plants other
than only Nicotiana spp. for producing proteins, and
thus an optimized CMV-based protein production sys-
tem would be very desirable. But CMV also has some
potential drawbacks for foreign protein production.
CMV has a tripartite single-stranded RNA genome and
each genomic RNA is packaged separately within icosa-
hedral capsids [5]. CMV genomic RNAs 1 and 2 encode
the 1a and 2a proteins, respectively, which are involved
in viral RNA replication [5,6]. RNA 2 also encodes a
small protein called 2b, which affects virulence and is
known to suppress the initiation of the plant defense,
RNA silencing, and to play a role in promoting cell-
to-cell movement [7]. RNA 3 also is bicistronic, encoding
the cell-to-cell movement protein (MP) and the virion
capsid protein (CP). All three CMV genomic RNAs are
essential for the systemic plant infection and all five
CMV-encoded proteins directly or indirectly affect the
movement of CMV within the plant host [5]. Still, CMV
genome segments 2 and 3 have been modified in some
cases for insertion of specific sequences which can give
foreign protein production in plants [4,8,9].
In our previous work we engineered a binary plasmid
to contain modified complementary DNAs (cDNAs)
representing the complete CMV tripartite genome, in
which the CMV coat protein gene was replaced by the
gene encoding α-1-antitrypsin [AAT] [9]. We deleted a
region of the CMV RNA 1 leader sequence to ensure
that the viral replicase was not able to replicate the trun-
cated RNA 1 and since coat protein was lacking, infec-
tious CMV was not generated thereby eliminatingpossible unwanted spread of the recombinant CMV.
Furthermore, because one of the key CMV-encoded pro-
tein components of the viral replicase (1a) is under the
control of a relatively tightly regulated chemically indu-
cible promoter (the XVE inducible promoter [10]), re-
combinant viral amplicons were produced intracellularly
only after addition of the inducer (β-estradiol). The high
efficiency and specificity are among the major advan-
tages of the XVE system, and thus it provides a potent
tool for research in plant biotechnology.
Despite the advantage of having all CMV components
on a single plasmid (e.g. ensuring that all CMV compo-
nents are simultaneously introduced into the same cell)
[9], the CMViva plasmid proved to not be easy for sub-
sequent manipulation. Its size alone (28 kbp) made
subsequent cloning manipulations difficult. Therefore,
here we explored development of new CMV-based smal-
ler-sized variants by separating genome components
onto different plasmids to give a bipartite inducible
(CMVin, CMV-based inducible system) and tripartite,
autonomously replicating forms of CMV (CMVar, CMV-
based advanced replicating system). We also assessed
the effects of mRNA4 leader sequence variants and com-
pared two CMV genotypes for their abilities to give in
planta production of two proteins, the green fluorescent
protein (GFP) and the Acidothermus cellulolyticus endo-
1, 4-β-glucanase (E1), a cellulose degrading enzyme. This
heat-stable, 56,000 MW well-studied endoglucanase has
been produced previously in different species of trans-
genic plants [11-13], and is believed to have potential
application for cellulose biomass conversion to sugars
and use in biofuel production. Here we show that active
E1 can be rapidly produced in non-transgenic plants by
using agroinfiltration with the CMV-based systems. This
reduces the time and energy required to generate trans-
genic plants and still gives the comparable yields of ac-
tive E1 to those obtained previously by others.
Methods
Plants and photography
Three-week-old Nicotiana benthamiana plants and nine
day old zucchini squash (Cucurbita pepo L. cv. Green
Bush) plants were used for virus inoculations or agroin-
filtration. Plants were photographed with a Cannon G6
digital camera equipped with a Tiffen Deep Yellow 15
filter. For photographing GFP expression, plants were
illuminated with a hand-held long-wave UV lamp.
Cloning and plasmid construction
In order to develop CMVin (CMV-based inducible sys-
tem) and CMVar (CMV-based advanced replicating sys-
tem), the gene-of-interest was inserted into the coat
protein coding region of CMV-Q RNA 3 (GenBank:
M21464) [14] to give pCMVar RNA 3. We modified the
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the mRNA 4 leader sequence, by PCR primer tagging to
introduce additional restriction enzyme sites for easier
cloning. This was done by PCR amplifying the CP cod-
ing region using tagged forward primers (EATG for se-
quence 2, HATG for sequence 6, PHATG for sequence
8, and CPfwd for the wild type leader sequence, Table 1)
and the reverse primer (CPrev listed in Table 1), and
GoFlexi Taq DNA polymerase (Promega Corp., Madison,
WI, U.S.A.). Amplified fragments were transferred to
pGEM-T Easy (Promega Corp., Madison, WI, U.S.A.)Table 1 List of primers used here




































33delrev CCCAGACGCATTTTGATTAAGAGand sequences were verified. Plasmids were then
digested by Pst I and Tth111 I, and the desired fragment
was transferred to pQA3 [9] (Additional file 1: Figure
S1). Then sequences containing the CaMV 35S (35S)
promoter, RNA 3 and 35S terminator were PCR ampli-
fied using primers 35SPfwd and 35STrev (Table 1) and
Pfu DNA polymerase (Stratagene, Agilent Technologies-
Company, U.S.A), and the resulting fragments were
ligated into the Sma I site of the mini binary vector,
pCB301 [15] (Additional file 1: Figure S1). These were
then used as the RNA 3 source for CMVar and CMVin
variants. The higher producing constructs (containing
the 2, 6, and 8 modified, and wildtype leader sequences
of RNA4; Additional file 2: Figure S2) were selected for
further experiments.
The E1 sequence (GenBank:HQ541433) used here was
first codon-optimized for dicots and constructed to con-
tain the rice alpha amylase (RAmy 3D, GeneBank:
M59351) signal peptide at its N’-terminus, and a 6-His
tag at its C’ terminus (synthesized by DNA2.0, Menlo
Park, CA, http://www.dna20.com, and provided as plas-
mid DNA pJL201:11772) ([16], see Figure 1A). The
green fluorescent protein (GFP) and E1 coding
sequences were PCR amplified and cloned into the CP
coding region of pCMVar RNA 3.
First, primer sets downstreamfwd and the Rna4wtrev,
Rna42rev, Rna46rev, Rna48rev (listed in Table 1), were
used for reverse PCR to remove the CP coding region
(Additional file 3: Figure S3). The E1 gene was amplified
by PCR using specific primers set (endoonlyfwd and
endoonlyrev as listed in Table 1) and ligated into coat
protein gene-deleted pCMVar RNA 3 by blunt end
ligation (Additional file 3: Figure S3), yielding pCMVar
E. The GFP coding sequence was PCR amplified from
pCMViva GFP [9] using the specific primer sets
(GFPfwd and GFPrev listed in Table 1), and cloned into
the coat protein region of pCMVar RNA 3 using
the same methods as for E1, resulting in pCMVar G
(Additional file 3: Figure S3).
To generate the CMVar replicating constructs, CMV
RNA 1 and RNA 2 segments (for CMV subgroup I and
II) were PCR amplified using the specific forward and
reverse primer sets (RNA1fwd and RNA12rev for sub-
group II RNA 1, RNA2fwd and RNA12rev for subgroup
II RNA 2, IRNA1fwd and IRNA12rev for subgroup I
RNA 1, IRNA2fwd and IRNA12rev for subgroup II RNA
2, respectively, as listed in Table 1). The RNA 3 region
of pCMVar RNA 3 was removed and replaced by the
RNA 1 or 2 genome segments and gave I and II pCMVar
RNA 1 and 2 (Additional file 4: Figure S4). The sub-
group I RNA 1 and RNA 2 were originally from a
California CMV [17], and the subgroup II RNA 1 and
RNA 2 were from CMV-Q (GenBank:X02733 for RNA
1, X00985 for RNA 2, respectively).
Figure 1 (A) Diagram of the E1 constructs and (B) Modified RNA 4 leader sequences containing restriction enzyme sites compared to
unmodified wild type (wt) leader sequences. (A) Gene structure of the E1 used in this report. The E1 gene contains the rice amylase signal
peptide in the upstream of its ORF and a 6 histidine-tag in its C-terminus. RAmySP; rice amylase signal sequence. This Figure is not to scale.
(B) Restriction endonuclease sequences are shown as italicized and underlined, the CP start codon (AUG) is shown in bold. Modified leader
sequences are located between the wildtype leader sequence and AUG start codon in subgenomic RNA4. Wt, wildtype leader sequence; 2+,
modified #2 leader sequences addition to the wildtype leader sequence; 6+, modified #6 leader sequences addition to the wildtype leader
sequence; 8+, modified #8 leader sequences addition to the wildtype leader sequence.
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from pDUXLR1R2 (pR1R2; [9] which includes the modi-
fied RNA 1 sequence. The monopartite inducible
CMViva expression system, pCMV containing all three
CMV genomic RNA segments in a single plasmid was
used as control [9]. The plasmid, pCassQ123, containing
all three CMV RNA segments in a single plasmid and
each driven by the 35S promoter was a gift from Dr.
ShouWei Ding, UC Riverside.
In order to construct the CMV MP 33 amino acid de-
letion mutants, we used PCR and the specific primer set
(33delfwd and 33delrev, listed in Table 1). PCR products
were eluted from an agarose gel and self ligated to make
pCMVar 33 G 2, 6, 8, wt and pCMVar 33E 2, 6, 8, wt
variants, respectively (Additional file 5: Figure S5).
Table 2 shows the names, activities and genotypes for
the expression system variants used in this paper.
Agroinfiltration
Binary plasmids purified from E. coli cultures were
transformed into Agrobacterium tumefaciens GV3101 or
EHA105 cells using electroporation. Transformed A.
tumefaciens cells were plated on Luria-Bertani plates
containing Rifampicin (10 μg/ml) and Gentamycin (20
μg/ml) for GV3101 and Kanamycin (50 μg/ml) for spe-
cific constructs, and Rifampicin (10 μg/ml) and Tetra-
cycline (10 μg/ml) for EHA105 and Gentamycin (20 μg/ml)for specific constructs, respectively. For agroinfiltration, a
single colony was inoculated into 5 ml L-MESA media
(100 ml LB broth, 2 ml 0.5 M MES (pH 5.7), 20 μl 0.1 M
acetosyringone) and grown to an OD600 of 1.0. Cells were
harvested by centrifuging for 10 min at 3,500 g and resus-
pended in induction media (50 ml sterile dH20, 0.5 ml 1 M
MgCl2, 1 ml 1 M MES (pH 5.7), 50 μl 0.1 M Acetosyrin-
gone), and allowed to sit at room temperature for 3 hrs be-
fore infiltration. When mixtures of A. tumefaciens cells
were infiltrated into plants, cultures were prepared separ-
ately in induction medium and combined immediately be-
fore infiltration. For inoculating small sugar pumpkin
plants, A. tumefaciens cells containing the constructs were
infiltrated into N. benthamiana plants. Leaves were har-
vested 6 days after infiltration, and used for standard rub
inoculation.
RNA extraction and realtime RT-PCR
Samples for RNA and protein extraction were harvested
from infiltrated and non-infiltrated leaves at 6 days after
infiltration. Total RNA was extracted using the RNeasy
kit (QIAGEN Inc., U.S.A.) following the manufacturer’s
instructions. Complementary DNA (cDNA) synthesized
from DNase-digested total RNA was used for reverse
transcription using the RNA 3end primer as listed in
Table 1 and SuperScript II Reverse Transcriptase, as
described by the manufacturer (Invitrogen, Carlsbad,





















































wt GFP Subgroup I R CMVarI 33Gwt
2 CMVarI 33 G2
6 CMVarI 33 G6
8 CMVarI 33 G8
wt GFP Subgroup II R CMVarII 33Gwt
2 CMVarII 33 G2
6 CMVarII 33 G6
8 CMVarII 33 G8
Table 2 Nomenclature and composition of CMV-based
systems (Continued)
wt GFP Subgroup II I CMVinII 33Gwt
2 CMVinII 33 G2
6 CMVinII 33 G6
8 CMVinII 33 G8












1All RNA3 constructs are from subgroup II CMV-Q. 2RNA 1 and 2 sources are
subgroup I or subgroup II as indicated. Cells containing required plasmids
were mixed and infiltrated into non-transgenic N. benthamiana plants as
described.
Hwang et al. BMC Biotechnology 2012, 12:66 Page 5 of 13
http://www.biomedcentral.com/1472-6750/12/66CA, U.S.A.). Realtime PCR was performed using gene
specific primers for each CMV RNA segment (realr-
na1fwd and realrna1rev for RNA 1, realrna2fwd and
realrna2rev for RNA 2, realrna3onlyfwd and realrna3on-
lyrev for RNA 3, realrna4onlyfwd and realrna4onlyrev
for RNA 4, and real18Sfwd, real18Srev for endogenous
18S control, respectively as listed in Table 1). Real-time
PCR was performed using SYBR Green PCR master mix
(Applied Biosystems, Life Technologies Corporation,
Carlsbad, CA, U.S.A.) in an ABI Prism 7500 Sequence
Detection system (Applied Biosystems, Life Technologies
Corporation, Carlsbad, CA, U.S.A.) under standard amp-
lification conditions (95°C for 5 min, followed by
40 cycles of 95°C for 15 s and 60°C for 1 min). The
threshold cycle (CT) is defined as the fractional cycle
number at which the fluorescence exceeded the fixed
threshold. Statistical analyses were performed using the
Bonferroni (Dunn) t test using the SAS 9.1 program.
Protein extraction and immunoblotting
Proteins were extracted from leaves using protein ex-
traction buffer (100 mM Tris–HCl (pH 8.0), 10 mM
EDTA, 5 mM DTT, 150 mM NaCl, 0.1% Triton X-100,
1X protease inhibitor (Roche diagnostics, Germany) and
tissue maceration using a bead-beater. Samples were
centrifuged at 12,000 g for 20 min to remove cell debris,
and protein concentrations were determined by Bradford
assay using Coomassie Plus (Pierce, Thermo Scientific,
IL, U.S.A.) with bovine serum albumin as the stan-
dard. Proteins were analyzed by SDS-PAGE in 12%
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membranes (Amersham Pharmacia Biotech, U.K.).
Membranes were incubated with rabbit CMV anti-CP
polyclonal antibody at 1:2,500 dilution, followed by goat
anti-rabbit IgG-alkaline phosphatase conjugate (Bio-Rad,
Hercules, CA, U.S.A.) at 1:2,500 dilution. For E1 detec-
tion, membranes were incubated with specific mouse
monoclonal IgG anti-E1 antibody (provided by Bill
Adney, National Renewable Energy Lab) at 1:2,500 dilu-
tion, followed by goat anti-mouse IgG alkaline phosphat-
ase conjugate (Bio-Rad, Hercules, CA, U.S.A.) at 1:2,500
dilution. After washing with Tris-buffered saline
(100 mM Tris-Cl, pH 7.5, 0.9% NaCl) with 0.3% Tween-
20 for three times, the membrane was developed to a
purple color using colorimetric AP conjugate substrate
reagent kit (Bio-Rad, Hercules, CA, U.S.A.) including
premixed BCIP (5-bromo-4-chloro-3-indolyl phosphate)
and NBT (nitroblue tetrazolium) substrate solutions
(Bio-Rad, Hercules, CA, U.S.A.).
Endoglucanase (E1) activity assays
Endoglucanase (E1) activity assays were done as
described [16]. A 60 μl aliquot of diluted supernatant
containing E1 was added to 540 μl of acetate buffer
(200 mM acetate, pH 5.5, 100 mM NaCl) and 200 μl of
substrate (500 μM methylumbelliferyl-tagged cellobiose
(MUC)). Then, 200 μl of the reaction was sampled at
time zero and after 30 min, and added to 800 μl of stop
buffer (150 mM glycine, pH 10). The change in fluores-
cence as released methylumbelliferine (MU) over time
was measured with a VersaFluor fluorometer (Bio-Rad,
Hercules, CA, U.S.A.). Fluorescence was converted to
activity, and specific activity was determined as
described [16].
Results
Modified RNA4 leader sequences affect mRNA and coat
protein levels
To facilitate cloning desired genes into the CMV CP re-
gion, we first created a separate CMV RNA 3-based
plasmid and modified the intergenic nucleotide sequence
upstream of the CP ORF start codon to contain desired
restriction endonuclease sites (Figure 1). This also
resulted in changes to the mRNA 4 nucleotide leader se-
quence immediately preceding the AUG start codon and
therefore could affect mRNA translation efficiency [18-
20]. Therefore, we first compared the respective CMVin
and CMVar variants for their ability to replicate and to
express CMV CP within infiltrated leaves. We used real-
time PCR to quantify levels of progeny RNAs 1, 2, 3,
and 3 plus 4 (because RNA 4 is a subset of RNA 3 and
is therefore difficult to differentiate from RNA 3).
When we compared the CMVinII variants with
CMViva, all showed accumulation of genomic andsubgenomic RNAs, and of CMV CP (Figure 2A). Be-
cause we are most interested in protein production from
RNA 4, comparison of the RNA 3 & 4 data show that
the modified variants (CMVinII 2, 6 and 8) all showed
slightly more RNAs 3 and 4 than did the wildtype
CMVinII, but none were higher than CMViva
(Figure 2A). Although the levels of RNAs 3 and 4 were
not statistically different, comparison of CMV CP accu-
mulation showed more CMV CP was detected for
CMVinII variants 2, 6, 8 and CMViva, than was for the
wildtype CMVinII. CMViva and CMVinII variants both
have 46 nucleotide deletions in the inducible CMV RNA
1 such that although it is transcribed and the resulting
RNA 1 serves for translation to yield the 1a protein, the
RNA 1 genome segment is not replicated as are genome
segments RNAs 2 and 3 (Additional file 2: Figure S2).
Because the 1a component of the replicase complex is
under the control of a relatively tightly regulated chem-
ically inducible promoter, the recombinant viral ampli-
cons are only produced under induction conditions.
When we compared the CMVarII variants, all showed
accumulation of all CMV RNAs, and so long as inocula
contained all three CMV genomic RNAs, accumulation
of RNAs 1, 2 and 3 was not significantly different for the
different variants. However, realtime PCR analysis
showed lower accumulation of RNAs 3 + 4 for CMVarII
variant6 when compared to the monopartite pQ123
(Figure 2B). All CMVarII variants showed much less CP
accumulation than was seen for pQ123, and CMVarII 2,
6 and 8 showed less CP than did CMVarII wt
(Figure 2B). However, all CMVarII variants were able to
initiate systemic infections in N. benthamiana and zuc-
chini squash plants (Additional file 6: Figure S6). RT-
PCR and nucleotide sequence analysis of the CMV
progeny showed that the modified leader sequences were
retained in RNAs extracted from systemically-infected
leaves (data not shown).
CMVinII and CMVarII variants yield high GFP fluorescence
To assess foreign protein production we first cloned the
gene for GFP into the CP coding region for the CMVinII
and CMVarII variants. Non-transgenic N. benthamiana
plants were infiltrated and leaves were examined for
fluorescence at 6 and 10 days post-infiltration. At 6 days
post-infiltration bright GFP fluorescence was seen in the
infiltrated regions (Figure 3). In general, the regions of
the leaves infiltrated with CMVinII and CMVarII var-
iants showed very bright fluorescence. By 10 days post-
infiltration, bright GFP fluorescence was observed for
the CMVinII and CMVarII variants, regardless of leader
sequence. Despite the fact that CMVarII variants produ-
cing the CMV CP spread within plants giving systemic
infections, CMVarII variants producing GFP did not,
and fluorescence was localized to the infiltrated areas.
Figure 2 (See legend on next page.)
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Figure 2 Relative RNA and coat protein accumulation levels for CMVinII and CMVarII variants having wt or modified RNA 4 leader
sequences. After 6 days post-infiltration, infiltrated leaves were harvested and total RNAs and proteins were extracted as described in Methods.
For CMVinII variants (see Table 2), estradiol was applied 18 hrs after infiltration using a cotton swab. For CMVinII variants, two leaves each from 3
plants for each treatment (n = 6) were used for 1st, 2nd biological trials, and three leaves each from 2 plants for 3rd, 4th trials (n = 6) yielding four
different biological trials (total n = 24). For CMVarII variants (see Table 2), two leaves each from 3 plants for each treatment (n = 6) were used for
analysis. These experiments were replicated three times (total n = 18). For immunoblot analysis, each lane was loaded with 15 μg of total protein.
Real-time PCR reactions were performed using an ABI 7500 with gene specific primer sets. Relative Ct values were calculated to the respective
18S rRNA relative concentration. Relative folds were calculated to the repective wildtype CMVinII and CMVarII value, respectively. Group
superscript letters next to the numbers represent different statistical groups, means with the same letter are not significantly different by the
Bonferroni (Dunn) t test using the SAS 9.1 program. Panel (A) CMVinII variants; H , healthy uninfiltrated leaf; pR1R2, pCMVinII RNA 1 and RNA 2
only; CMVinII wt , wt leader; CMVinII 2 , #2 leader; CMVinII 6, #6 leader; CMVinII 8 , #8 leader; CMViva, pCMV (see Methods). Panel (B) CMVarII
variants; H, healthy, uninfiltrated leaf; R1 + R2, pCMVarII RNA 1 and RNA 2 only; CMVarII wt , wild type leader; CMVarII 2 , #2 leader; CMVarII 6 ,
#6 leader; CMVarII 8, #8 leader; pQ123, pCassQ123 (see Methods).
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duce CMV CP, which is known to be a determinant of
CMV systemic spread in plants [21,22], and thus these
infections were localized to the infiltrated regions of the
treated leaves. We also tested another reporter protein,
the red fluorescent protein (RFP), for expression using
CMVinII and CMVarII and obtained essentially identical
results to those shown for the variants expressing GFP
(data not shown).
E1 was produced in plants using both CMVinII and
CMVarII variants
Our intent is to develop easy-to-use CMV variants that
give efficient production of desirable proteins in non-
transgenic plants, including proteins with potential
biofuel applications. Therefore, we next assessed E1 ac-
cumulation in leaves of infiltrated N. benthamiana
plants. We first used immunoblot analysis to detect total
E1 accumulation in leaves infiltrated with the CMVinII
and CMVarII variants. E1 was detected in the infiltrated
leaves for both CMVinII and CMVarII wild type variants
(Figure 4). The leader sequence CMVinII variants 6 and
8 showed higher E1 compared to the wildtype CMVinII.
For CMVarII variants, the wild type showed higher E1
accumulation, but the 6 and 8 variants also gave good
E1 accumulation (Figure 4). Interestingly, the intact E1
migrated as a ca. 72 KDa protein as shown in Figure 4
and Additional file 7: Figure S7, even though the calcu-
lated MW of E1 is 57.3 KDa, including the histidine tag
and rice amylase signal peptide (See Figure 1A). Similar
reports for anomalous E1 migration in SDS-PAGE have
been previously reported [16,23].
The immunoblot experiments showed E1 protein ac-
cumulation but our interest is in production of enzyma-
tically active E1. Therefore we used activity assays on
plant extracts to estimate yields of active E1. In repeated
experiments, the CMVinII E6 and E8 consistently
yielded 8 to almost 15 fold higher relative E1 accumula-
tion than wildtype CMVinII E, while the yield for CMVi-
nII E2 was negligible. By contrast, the wildtype CMVarIIE consistently yielded more E1 than the other CMVarII
variants (Table 3). CMVarII E2 gave negligible E1 accu-
mulation while CMVarII E6 and E8 showed low yields,
but much less than wildtype CMVarII E. We had antici-
pated that CMVarII would give higher protein accumu-
lation in plants because of RNA 1 replication, which is
lacking in CMVinII (Additional file 2: Figure S2), but
this proved not to be the case, the highest overall yields
were obtained with CMVinII E 6 and 8. The CMVarII is
easier to use since there is no requirement for adding
the RNA 1 inducer, estradiol, and if we could achieve
higher protein accumulation with CMVarII this would
be our choice. Therefore we next attempted to increase
CMVar-driven protein accumulation by two additional
approaches: to increase CMV RNA replication and to in-
crease CMV spread within plants.
Reassortant CMVarI variants yield more protein compared
to CMVarII variants
CMV is one of the world’s most widespread plant
viruses, and has many genetic variants which are primar-
ily divided into the taxonomic subgroups I and II [5]. In
general, subgroup I CMVs show more severe symptoms
in plants than do subgroup II CMV isolates, which can
show mild or even symptomless infections. This is sug-
gested to be associated with the 2b protein (encoded by
RNA 2) as a silencing suppressor [24], and effects can
vary in different plant hosts [25]. Therefore, we gener-
ated and compared CMV subgroup I and II genomic
reassortants for their abilities to give greater replication
and protein production. All reassortants contained the
same CMV subgroup II wildtype RNA 3 or variant con-
structs for GFP or E1. GFP fluorescence was brighter for
all CMVarI variants compared with the respective
CMVarII variants (Figure 5). We next compared produc-
tion of active E1 among the CMVarI and II E variants by
immunoblotting (Additional file 7: Figure S7) and found
that the reassortant wildtype CMVarI E gave more active
E1 than did CMVarII E in side-by-side experiments
(Table 3 and Additional file 7: Figure S7). By contrast,
Figure 3 GFP fluorescence for CMVinII and CMVarII wt and leader sequence variants in N. benthamiana plants. CMVinII G and CMVarII G
(see Table 2) columns are indicated for both 6 and 10 days after infiltration. Rows show relative GFP fluorescence for leader sequence variants.
A. tumefaciens cells containing respective plasmids were mixed just before leaf infiltration. CMVinII G plants then had estradiol induction
treatments 18 hrs after infiltration. Photos were taken under long wavelength UV light.
Figure 4 Immunoblot analysis of E1 produced in infiltrated N.
benthamiana leaves. N. benthamiana leaves were co-infiltrated
with A. tumefaciens containing plasmids corresponding to the
CMVinII E and CMVarII E variants (see Table 2) shown. CMVinII E
leaves were treated with estradiol 18 hrs after infiltration. Leaves
were harvested 6 days post-infiltration. Soluble proteins were
extracted as described in Methods and concentrations were
determined by Bradford assay. Numbers above each lane
correspond to the specific RNA 3 variant used. Each sample
represents 15 μg total protein extract per lane. Prestained size
marker (Benchmark, Invitrogen, Carlsbad, CA, U.S.A.) shows 80 kDa
band.
Table 3 Amount of active E1 (μg/g FW) in infiltrated N.
benthamiana leaves using the different CMVin and CMVar
leader sequence variants
-wt −2 −6 −8
CMVinII E 1.09 ± 0.201D −0.01 ± 0.00D 14.74 ± 2.14A 13.97 ± 3.40A
1.07 ± 0.80E 0.22 ± 0.36E 8.76 ± 3.49BC 9.38 ± 2.10BC
1.00 ± 0.45D 0.76 ± 0.11D 10.05 ± 1.28B 11.05 ± 3.85B
CMVarII E 2.23 ± 0.59CD 0.00 ± 0.01D 0.10 ± 0.08D −0.01 ± 0.00D
6.30 ± 3.50CD 0.01 ± 0.03E 0.33 ± 0.33E 0.05 ± 0.12E
10.78 ± 3.63BC −0.01 ± 0.01D 1.58 ± 0.49D 1.85 ± 1.13D
CMVarI E 4.12 ± 3.35CD 0.00 ± 0.01D 0.67 ± 0.36D −0.01 ± 0.00D
9.38 ± 2.10AB 0.00 ± 0.01E 0.57 ± 0.45E 0.38 ± 0.79E
15.15 ± 5.39AB 0.39 ± 0.30D 1.88 ± 0.32D 1.28 ± 0.53D
CMVarII 33E 6.74 ± 2.82BC 0.08 ± 0.12D 1.17 ± 0.82D 2.27 ± 1.81D
5.61 ± 2.01CDE 0.01 ± 0.01E 1.87 ± 0.64DE 1.15 ± 0.77DE
14.06 ± 2.71AB 0.21 ± 0.26D 1.17 ± 0.98CD 1.72 ± 0.93CD
CMVarI 33E 11.34 ± 2.67AB 1.42 ± 0.33D 2.26 ± 0.36CD 1.31 ± 0.81CD
19.60 ± 4.56A 1.49 ± 0.14DE 2.03 ± 0.31CE 1.73 ± 1.09DE
20.99 ± 5.18A 1.16 ± 0.96D 1.97 ± 0.48D 2.49 ± 1.61D
1Numbers indicate E1 production as μg/g fresh weight. Average ± standard
deviations are shown. Samples were collected 6 days post-infiltration, using 3
plants, 2 leaves from each plant (n = 6) for each biological trial. Results for
three different biological trials are shown for each test. The identities of
variants tested are given in Table 2. Group superscript letters next to the
numbers represent different statistical groups, means with the same letter
are not significantly different by the Bonferroni (Dunn) t test using the
SAS 9.1 program.
Hwang et al. BMC Biotechnology 2012, 12:66 Page 9 of 13
http://www.biomedcentral.com/1472-6750/12/66
Figure 5 Comparison of GFP fluorescence from CMVarI G and CMVarII G variants. N. benthamiana leaves were co-infiltrated with
A. tumefaciens containing plasmids corresponding to the CMVarI and II G variants (see Table 2) as shown at Panel A. Numbers for leaves in
panel at right indicate specific RNA 3 variant. Photographs were taken 6 days post-infiltration under UV light shown as Panel B.
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lation. However, wildtype CMVarI E gave relatively high
E1 accumulation, similar to that for CMVinII E variants
6 and 8.
The MP C-terminal 33 amino acid deletion constructs
showed increased yields compared to the intact MP
constructs
CMV requires both the MP and CP for cell-to-cell
movement in plants, both of which are encoded by RNA
3 [5,26]. Thus for both CMVar and CMVin variants,
when foreign sequences are cloned into the CP coding
region, there is no cell-to-cell movement due to lack of
the CMV-encoded CP, and the desired recombinant pro-
teins (GFP or E1) accumulate only in the initially-
infected cells. However, it was shown previously that
when the CMV MP was mutated so as to lack the C-
terminal 33 amino acids, CMV infections were able to
move cell-to-cell in plants even in the absence of CP
[27]. Therefore, we deleted the MP C-terminal 33 amino
acids and compared E1 and GFP accumulation in plants
using the CMVarI and CMVarII variants. GFP fluores-
cence was high for all variants with the 33 amino acidFigure 6 Comparison of GFP fluorescence CMVarI 33 G and CMVarII 3
with A. tumefaciens containing plasmids corresponding to the CMVarI and
leaves in Panel B at right indicate specific RNA 3 variant containing MP del
shown as Panel B.truncated MP (Figure 6). However, comparing E1 accu-
mulation for all variants, the highest levels of active E1
were obtained for the 33 amino acid truncated CMVarI
Ewt variant (Table 3). Our assays were for intact, enzy-
matically active E1, and we obtained yields up to 21 μg/g
of active E1, corresponding to ~0.4% of TSP. Further-
more, unlike for the wildtype MP variants, the CMVinII
33E variants 6 and 8 gave relatively low accumulation
of E1.
Discussion
Several different viruses have been used for protein pro-
duction in plants, and each has advantages as well as
disadvantages [28-32]. Many of the “first generation”
plant virus vectors [28,33] utilized whole plant systemic
virus infections to give desired proteins. While many of
these have proven to be very useful there are some sig-
nificant drawbacks. Systemic infections can take several
days to fully develop. Protein production is then asyn-
chronous and yields can vary in different tissues [3]. Re-
combinant viruses also show size constraints for the
inserted sequence, often coding sequences of only 1 kb
or less (encoding a protein of only ~35 kDa) can be3 G MP deletion mutants. N. benthamiana leaves were co-infiltrated
II 33 G variants (see Table 2) as shown at left Panel A. Numbers for
etion. Photographs were taken 6 days post-infiltration under UV light
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partially or completely excise the inserted recombinant
sequence, leading to loss of the desired intact protein
product [28,35]. Furthermore, some viruses (e.g. those
with icosahedral capsids such as CMV) may have even
more severe size constraints if RNA encapsidation is a
requirement for development of the systemic infection.
Then if the coding sequence for the desired protein is
large, insertion into the viral RNA may preclude encap-
sidation, thereby preventing efficient spread.
Recent progress in developing Agrobacterium tumefa-
ciens delivered plant virus-based protein production sys-
tems has been made by several research groups using
different plant viruses [31,34,36]. These plant virus-
based amplicon systems offer many advantages including
the fact that non-transgenic plants can be used, the
desired protein production is rapid, the product can ac-
cumulate to high levels, and virus-based expression can
be temporally regulated to be almost synchronous in all
infiltrated areas. Because a majority of the infiltrated
cells become simultaneously infected, virus move-
ment to new cells is not necessary, encapsidation of re-
combinant RNAs is not an issue. These “second
generation” virus-based systems also can retain larger
foreign coding sequences and thus produce larger pro-
teins in plants [34], here we produced enzymatically ac-
tive 56,000 MW E1.
In our previous work, we used the estradiol-inducible,
CMV-based CMViva to produce α anti-trypsin (AAT) in
non-transgenic N. benthamiana plants [9]. CMViva has
all three CMV genome components in one large 28 kbp
plasmid, which, due to its large size is difficult to ma-
nipulate. Thus, here we took approaches to develop
CMV-based inducible (CMVin) as well as autonomously
replicating (CMVar) systems, both of which are more
easily manipulated and might be able to give high accu-
mulation of heterologous proteins in plants. First, we
separated the CMV genomic RNA cDNAs onto two
plasmids, one containing the RNA 1 and 2 replication-
associated genome components and the other containing
the CMV RNA 3 genome segment. The CMV RNA3
component is rather small in size, 2.2 kb, and is easy to
manipulate and to engineer to contain restriction en-
zyme sites to allow for easy removal of the CMV CP
gene and replace it with any gene of interest. The
desired restriction enzyme sites were introduced into the
intergenic region of RNA 3. As expected, these altered
the 50 untranslated leader sequence of the resulting
mRNA (RNA 4). The sgRNA promoter (for RNA 4 tran-
scription) is within the minus strand of RNA 3 and is
recognized by the RNA-dependent RNA polymerase and
mRNA transcription is initiated. For CMV-Q RNA3, the
transcription initiation starts at nt position 1167 in the
intergenic region, which is upstream of the modifiedleader sequences. Our analyses demonstrated that the
RNA 3 modifications affected RNA 3 and RNA 4 accu-
mulation, but showed even more unpredictable effects
on resulting protein accumulation. It does not appear
that these can be attributed only to start codon context
[18,19] as the same construct (RNA 3) showed different
protein yields whether the RNA was delivered using
CMVin vs. CMVar.
In contrast to CMViva, both CMVinII and CMVarI
and II variants require mixing A. tumefaciens cells con-
taining different plasmids which are then co-infiltrated
into plants and T-DNA from the different A. tumefa-
ciens cells containing the CMV plasmids must be trans-
ferred to the same plant cell for the complete CMV
amplicon. For CMVinII variants this is then followed by
induction using estradiol, which resulted in high level
accumulation of the proteins tested here (CP, GFP, E1).
However, like for CMViva, the CMVinII RNA 1 deletion
does not allow for its replication, only translation of the
newly transcribed mRNA. Therefore we also developed
the non-inducible autonomously replicating CMV-based
system, CMVarI and II. Wildtype CMVar (expressing
the CMV CP) replicated to very high levels and even
caused systemic infections in plants. However, when
genes for GFP or E1 were substituted for the CP gene,
both proteins were produced in plants within the infil-
trated areas, and quantitative analyses showed that high
levels of proteins accumulated for both CMVin vs.
CMVar, particularly at 6 days post-infiltration.
Although CMVinII E 6 and 8 variants gave slightly
more active E1 in most experiments, CMVarI and II var-
iants offers advantages in ease of use (e.g. no need to
add the inducer) and thus, two additional approaches to
improve accumulation of the desired protein product
were investigated. Like most viruses having genomes
composed of multiple segments, CMV genomic RNAs
can be mixed (reassortment) to achieve genetic diversity
[37,38], and this offers opportunities for using CMV to
produce desirable proteins in different plant species, as
has been demonstrated also by others [3]. Therefore, we
generated CMV reassortant genotypes by substituting
CMV subgroup I genomic RNAs 1 and 2 derived from a
more virulent CMV, with the original CMV Q subgroup
II RNA 3, giving CMVarI. Comparison of CMVarI and
CMVarII G, E variants showed higher GFP and E1 for
CMVarI G, E variants. However, the CMVarI Ewt
showed higher E1 accumulation than did the corre-
sponding CMVinII Ewt, but CMVinII E variants 6 and 8
gave the higher E1 accumulation than CMVar I 6 and 8
variants thus showing that reassortment alone was not
sufficient.
As another alternative, we generated a MP C-terminal
33 amino acid deletion mutant. Cell-to-cell movement
in CMV-infected plants requires interactions between
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CMViva, CMVarI and II and CMVinII are cell-to-cell
movement deficient since they lack the CP and thus,
desired recombinant proteins are produced only within
infiltrated cells. However, previous workers demon-
strated that the CMV MP C-terminal 33 amino acids are
essential to recognize and interact with the CP [26].
When this region is deleted, the CMV infections can
spread cell-to-cell even in the absence of CP [27]. In
support of this the CMVarI and CMVarII 33 G variants
showed high CMV-based GFP production (Figure 6; and
see [4]). When we created MP 33 amino acid deletion
constructs and tested them, they showed increased pro-
duction of not only GFP in CMVarI and II 33 G var-
iants, but also of E1 in CMVarI and II 33E variants
(Table 3, Figures 5 and 6), and the highest yields of ac-
tive E1 were obtained using the CMVarI 33E variants.
Other workers have produced versions of E1 in various
transgenic plants with gene expression driven by differ-
ent promoters. For example, full-length E1 containing
the catalytic domain, linker and carbohydrate binding
domain has been previously produced in transgenic
tobacco plants. Based on the resulting E1 activity, yields
of up to 0.25% on average of total leaf soluble proteins
were shown with Mac promoter, a chimeric promoter of
the CaMV 35S and mannopine synthase gene [11]. Simi-
lar yields were shown also with CaMV 35S promoter
[13]. In transgenic Z. mays seeds, the full-length E1 was
produced using Glob-1 (Maize embryo-preferred globu-
lin-1 promoter) and yields up to 6% TSP were obtained
[39]. In transgenic rice (Oryza sativa) plants, 35S driven
E1 lacking the carbohydrate binding domain but only
containing the catalytic domain gave yields up to 4.9%
TSP [40]. Thus, our yields of up to 0.4% TSP of intact
E1 in nontransgenic N. benthamiana plants are similar
to those achieved for intact E1 in transgenic tobacco,
but less than those in more specialized systems. Further-
more, CMVin and CMVar-based production of the
desired protein can be temporally regulated to give al-
most synchronous protein accumulation over a very
short time period, even a few days.
Conclusions
Our data demonstrate that the CMV-based systems,
CMVin and CMVar, are good candidates for production
of desired heterologous proteins in nontransgenic plants.
Our modifications described here, including manipulat-
ing cloning sites for foreign gene introduction, enhance
the ease of their use, and reassortant genotypes and
CMV movement protein deletions also allow for greater
protein accumulation. Also, N. benthamiana, which is
particularly suitable for agro infiltration, is a very good
plant for protein production, but due to the wide hostrange of CMV, other plants may also prove to be useful
for production of different proteins.
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